UCSF Health鈥檚 Lung Transplant program has been awarded INTERLINK鈥檚 2025 Chairman鈥檚 Award for Transplant Excellence as the top-performing lung transplant program in the nation. The UCSF program, which is the largest lung transplant program in the Western U.S., was selected as the No.1 performing program for lung transplantation for the third consecutive year.
A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be deadly when left untreated. Researchers from UC San Francisco (UCSF) and Mass General Brigham found that electronic messages sent to providers within one week of patients receiving an echocardiogram improved care for patients with severe AS 鈥� including higher rates of treatment with aortic valve replacement (AVR), particularly in symptomatic patients.
To determine the underlying causes of neuronal vulnerability at the earliest stages of Alzheimer's disease (AD), a research team from the UC San Francisco鈥檚 Memory & Aging Center made use of brain tissue samples from two brain regions with differing susceptibility to AD.
The study, appearing in the March 25 edition of eBioMedicine (open-access journal from The Lancet), found that using intracranial EEG recordings with high-density arrays resulted in better appraisals and better agreement about the location of SOZ among the epileptologists, compared to lower-density recordings.
To determine whether self-guided mindfulness could prove a potent tool in combatting workplace stress and burnout, researchers from the UC San Francisco Department of Psychiatry and Behavioral Sciences launched a large mindfulness trial for over 1,400 UCSF employees.
HS PROGRESS is designed to facilitate hidradenitis suppurativa (HS) research through collaboration between investigators, clinicians, patients and industry in order accelerate the development of therapies to improve the lives of people living with this skin painful condition.
UCSF Benioff Children's Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell disease. The trial is the first in the U.S. to apply non-viral CRISPR-Cas9 gene-editing technology in humans to directly correct the genetic mutation that causes the disease.
A new international trial is investigating the efficacy and safety of gene therapy in patients with Hurler syndrome and will compare results of gene therapy against BMT which is the current standard of care. UCSF Benioff Children鈥檚 Hospitals are among three sites in the U.S. and seven in the world now enrolling patients for the clinical trial.
Two UC San Francisco faculty members, Alicia Fernandez, MD, professor of medicine, and Nola M. Hylton, PhD, a professor of radiology and biomedical imaging, have been elected to the National Academy of Medicine (NAM) this year, one of the highest honors in the field of health and medicine.
Researchers from UC San Francisco have developed a machine learning algorithm to enhance 3T MRIs by synthesizing 7T-like images that approximate real 7T MRIs. Their model enhanced pathological tissue with more fidelity for clinical insights and represents a new step toward evaluating clinical applications of synthetic 7T MRI models.
Recent results from one of the I-SPY 2.2 study arms, published September 14, 2024 in Nature Medicine, showed that neoadjuvant treatment with the antibody-drug conjugate datopotamab鈥揹eruxtecan (Dato-DXd) in combination with the immune checkpoint inhibitor, durvalumab (Imfinzi), produced high rates of pCR in patients who have an immune breast cancer subtype as well as a subtype of triple negative cancer that would ordinarily have a high risk of recurrence.
Mack Roach, III, MD, FASTRO, has been chosen by the American Society for Radiation Oncology (ASTRO) to receive its 2024 Gold Medal Award. Roach is being recognized with ASTRO鈥檚 highest honor for his outstanding contributions to the field of radiation oncology.
The UCSF Helen Diller Family Comprehensive Cancer Center announced today that the UCSF Prostate Cancer Program is the recipient of the National Cancer Institute鈥檚 (NCI) Specialized Programs of Research Excellence (SPORE) grant for prostate cancer.
The UCSF Lung Transplant Program has performed over 100 transplants in a year, making it one of a handful of medical centers in the nation to reach that milestone.
To provide more personalized treatment for Parkinson's Disease based on individuals鈥� disease state and progression, researchers at the University of California San Francisco (UCSF) developed a video-based analysis system enabled by machine learning (ML), to quantify and validate motor symptom severity in patients with Parkinson鈥檚 Disease (PD).
Hospitalized patients with complex dietary restrictions often develop hyperglycemia (high blood sugar), leading to serious complications particularly in those with preexisting diabetes. UCSF endocrinologist Robert J. Rushakoff, MD, and his team developed a self-adjusting subcutaneous insulin algorithm (SQIA) for automatically adjusted dosing.
Gastrointestinal cancer surgeons at the UC San Francisco have performed the health system鈥檚 15,000th robotically assisted minimally invasive surgery, making it the first University of California health center to reach this milestone.
Gastrointestinal cancer surgeons at the UC San Francisco have performed the health system鈥檚 15,000th robotically assisted minimally invasive surgery, making it the first University of California health center to reach this milestone. UCSF Health has the busiest robotic surgery program in the UC health system and is the leading academic medical institution for robotic surgeries in the western U.S.
In a discovery that could hasten treatment for patients with multiple sclerosis (MS), UC San Francisco scientists have discovered a harbinger in the blood of some people who later went on to develop the disease.鈥�
Bruce Ovbiagele, MD, MSC, MAS, MBA, MLS, FAAN, UC San Francisco Professor of Neurology and Associate Dean of the San Francisco VA Healthcare System, has been chosen by the American Brain Foundation (ABF) to receive its annual Scientific Breakthrough Award.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 麻豆传媒 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right